1. IL‐27 enhances the survival of tumor antigen‐specific CD8+ T cells and programs them into IL‐10‐producing, memory precursor‐like effector cells. Issue 2 (15th January 2013) Authors: Liu, Zhenzhen; Liu, Jin‐Qing; Talebian, Fatemeh; Wu, Lai‐Chu; Li, Shulin; Bai, Xue‐Feng Journal: European journal of immunology Issue: Volume 43:Issue 2(2013:Feb.) Page Start: 468 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Interleukin‐27 signalling induces stem cell antigen‐1 expression in T lymphocytes in vivo. Issue 4 (23rd August 2017) Authors: Liu, Zhihao; Wu, Lisha; Zhu, Jing; Zhu, Xiaotong; Zhu, Jianmin; Liu, Jin‐Qing; Zhang, Jianchao; Davis, Jonathan P.; Varikuti, Sanjay; Satoskar, Abhay R.; Zhou, Jie; Li, Ming‐Song; Bai, Xue‐Feng Journal: Immunology Issue: Volume 152:Issue 4(2017) Page Start: 638 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Systemic delivery of IL‐27 by an adeno‐associated viral vector inhibits T cell‐mediated colitis and induces multiple inhibitory pathways in T cells. Issue 2 (22nd April 2016) Authors: Zhu, Xiaotong; Liu, Zhihao; Liu, Jin‐Qing; Zhu, Jianmin; Zhang, Jianchao; Davis, Jonathan P.; Chu, Jianhong; Yu, Jianhua; Zhou, Jie; Li, Ming‐Song; Bai, Xue‐Feng Journal: Journal of leukocyte biology Issue: Volume 100:Issue 2(2016) Page Start: 403 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗